These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5043228)

  • 41. Lack of correlation between clinical and angiographic findings in patients with brain tumors under BCNU chemotherapy.
    Koo AH; Fewer D; Wilson CB; Newton TH
    J Neurosurg; 1972 Jul; 37(1):9-14. PubMed ID: 4338690
    [No Abstract]   [Full Text] [Related]  

  • 42. [Significance of cellular kinetics in relation to chemotherapy of human leukemias].
    Alberto P
    Schweiz Med Wochenschr; 1971 Oct; 101(42):1510-5. PubMed ID: 5143015
    [No Abstract]   [Full Text] [Related]  

  • 43. Response of advanced breast cancer to two dosage regiments of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Bonnet JD; Brownlee RW; Vaitkevicius VK; Talley RW
    Cancer Chemother Rep; 1973 Apr; 57(2):231-4. PubMed ID: 4742501
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
    Denes AE; Presant CA; Bartolucci A
    Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
    [No Abstract]   [Full Text] [Related]  

  • 46. Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases.
    Creagan ET; Eagan RT; Rubin J
    Med Pediatr Oncol; 1979; 7(2):179-80. PubMed ID: 502975
    [No Abstract]   [Full Text] [Related]  

  • 47. Some thoughts on surgical adjuvant studies in lung cancer.
    Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
    [No Abstract]   [Full Text] [Related]  

  • 48. Informal discussion: experimental basis for the chemical eradication of leukemia.
    Frei E
    Cancer Res; 1967 Dec; 27(12):2656-7. PubMed ID: 6082303
    [No Abstract]   [Full Text] [Related]  

  • 49. Alkylating activity of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds.
    Wheeler GP; Chumley S
    J Med Chem; 1967 Mar; 10(2):259-61. PubMed ID: 6034073
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of 1,3-bis(2-chlorethyl)-1-nitrosourea (NSC-409962) and nitrogen mustard (NSC-762) on kinetic behavior of cultured L1210 leukemic cells.
    Wilkoff LJ; Dixon GJ; Dulmadge EA; Schabel FM
    Cancer Chemother Rep; 1967 Feb; 51(1):7-18. PubMed ID: 6039664
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacokinetics of the antineoplastic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the aqueous and vitreous of rabbit.
    Ueno N; Refojo MF; Liu LH
    Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):199-208. PubMed ID: 7096015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amphotericin B plus 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC no. 409962) in advanced cancer. Phase I and preliminary phase II results.
    Presant CA; Klahr C; Olander J; Gatewood D
    Cancer; 1976 Nov; 38(5):1917-21. PubMed ID: 991105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bronchogenic carcinoma, stages 3 and 4. Palliation by chemotherapy.
    Roswit B
    JAMA; 1966 Jun; 196(10):848-9. PubMed ID: 4160792
    [No Abstract]   [Full Text] [Related]  

  • 54. Pilot study evaluating 1,3-bis(2-chloroethyl)-1-nitrosourea in the treatment of advanced ovarian carcinoma.
    Jorgensen EO; Malkasian GD; Webb MJ; Hahn RG
    Am J Obstet Gynecol; 1973 Jul; 116(6):769-70. PubMed ID: 4577261
    [No Abstract]   [Full Text] [Related]  

  • 55. A toxicologic comparison of the potency and activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in mice and rats.
    Thompson GR; Larson RE
    Toxicol Appl Pharmacol; 1972 Mar; 21(3):405-13. PubMed ID: 5027972
    [No Abstract]   [Full Text] [Related]  

  • 56. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y; Hoshino T; Barker M; Deen DF
    Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 58. BCNU (1,3,bis(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia.
    Lessner HE
    Cancer; 1968 Aug; 22(2):451-6. PubMed ID: 4873194
    [No Abstract]   [Full Text] [Related]  

  • 59. The uptake, distribution, and antitumor activity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the murine glioma.
    Levin VA; Shapiro WR; Clancy TP; Oliverio VT
    Cancer Res; 1970 Oct; 30(10):2451-5. PubMed ID: 5474173
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.